Vivek Roy

18PUBLICATIONS

65CO-AUTHORS

Haematological tumoursRadiation therapyHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|May 07, 2026

A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia.

|Apr 22, 2026

A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Dec 05, 2025

Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.

Arni Kumar, Arin Singh, Tea Reljic

|Oct 15, 2025

AL amyloidosis: a real-world experience with CAR T-cell therapy.

Melinda S Y Tan, Rahma Warsame, Ricardo Parrondo

|May 23, 2025

Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

Ricardo D Parrondo, Saurav Das, Hanna Sledge

|Apr 04, 2025

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.

Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar

Pageof 3

Frequent Collaborators

11 joint publications

Ricardo Parrondo

10 joint publications

Sikander Ailawadhi

Angela Dispenzieri

P Leif Bergsagel

Shaji Kumar

Moritz Binder

Nelson Leung

Taxiarchis V Kourelis

6 joint publications

Morie Gertz

6 joint publications

Eli Muchtar

Frequent Collaborators

11 joint publications

Ricardo Parrondo

10 joint publications

Sikander Ailawadhi

9 joint publications

Angela Dispenzieri

8 joint publications

P Leif Bergsagel